Affirming support for most-favored-Nation drug pricing for United States patients.
Sponsored By: Representative Dingell
Introduced
Summary
This resolution would endorse aligning U.S. drug prices with those in other developed countries. It also supports expanding Medicare drug price negotiation and promoting price competition to lower costs.
Show full summary
- Families and patients: Would aim to reduce out-of-pocket costs and cut cost-related nonadherence. Polling cited 21% did not fill a prescription and 1 in 7 cut or skipped doses because of cost.
- Medicare beneficiaries: Would back expanding Medicare drug price negotiation to seek lower prices for drugs covered by Medicare.
- Drug market: Would support policies that tie U.S. prices to those paid abroad and encourage competition among manufacturers.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Dingell
MI • D
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in